Recent News

• 04.22.2025 - Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System
• 04.16.2025 - The History of Fingerprint Drug Testing
• 03.31.2025 - Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
• 03.27.2025 - Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
• 03.26.2025 - Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
• 03.25.2025 - Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
• 03.24.2025 - How Does Fingerprint Drug Testing Compare to Urine and Saliva?
• 03.20.2025 - Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

Recent Filings

• 04.11.2025 - S-3 Registration statement under Securities Act of 1933
• 04.01.2025 - DEF 14A Other definitive proxy statements
• 04.01.2025 - ARS Annual Report to Security Holders
• 03.31.2025 - 4/A Statement of changes in beneficial ownership of securities
• 03.26.2025 - EX-99.1 EX-99.1
• 03.26.2025 - 8-K Current report
• 03.25.2025 - 8-K Current report
• 03.25.2025 - EX-99.1 EX-99.1
• 03.21.2025 - EX-99.1 EX-99.1
• 03.21.2025 - 8-K Current report